Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small interfering RNA (siRNA) candidates in epilepsy and Huntington’s disease.

You could get a rugged Mercedes van filled with creature comforts, could fit a camper shell to your trusty truck or could opt for a Kei truck fitted with this awesome pod that transforms the tiny ...